Pharmacology British Journal of Pharmacology
Amylin-Type Receptor Joins CGRP Receptor in Driving Migraine Light Aversion, but Not Diarrhoea, in Mice
- In mice, CGRP and amylin each triggered light aversion, a migraine-like behaviour, and diarrhoea.
- The CGRP receptor blocker olcegepant failed to stop CGRP-driven light aversion, whereas the amylin-type antagonist AC187 helped partly; only the combination fully reversed it.
- Diarrhoea tracked mainly with the canonical CGRP receptor, suggesting AMY1 is a distinct target for photophobia.
Olcegepant alone failing to block CGRP-driven light aversion, while it fully blocks periorbital allodynia, is the useful dissociation: it implies photophobia runs through AMY1, not just the canonical receptor. But AC187 is a weakly selective peptide antagonist, so I'd confirm with a second AMY1-selective tool or knockout, plus exposure data, before calling AMY1 a standalone target.
Paper: British Journal of Pharmacology ↗ Differing roles of the calcitonin gene‐related peptide (CGRP) and amylin receptors in migraine‐related light aversion and gastrointestinal dysfunction in mice